# Estradiol-Receptor Blockade in Older Men and Women

> **NCT02271282** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 40 (actual)

## Conditions studied

- Normal Healthy Volunteers

## Interventions

- **DRUG:** Toremifene
- **DRUG:** Placebo
- **DRUG:** GHRH/Ghrelin combined Injection

## Key facts

- **NCT ID:** NCT02271282
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271282, "Estradiol-Receptor Blockade in Older Men and Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02271282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*